|
BTBD10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64000000246745E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11600000352041E-08 |
| Normal-vs-Stage2 |
4.644200E-02 |
| Normal-vs-Stage3 |
1.426210E-04 |
| Normal-vs-Stage4 |
1.962670E-03 |
| Stage1-vs-Stage2 |
1.381440E-01 |
| Stage1-vs-Stage3 |
6.100200E-01 |
| Stage1-vs-Stage4 |
4.770800E-01 |
| Stage2-vs-Stage3 |
3.592000E-01 |
| Stage2-vs-Stage4 |
5.133600E-01 |
| Stage3-vs-Stage4 |
7.948400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.15259999825079E-08 |
| Normal-vs-AfricanAmerican |
1.102160E-02 |
| Normal-vs-Asian |
1.963620E-04 |
| Caucasian-vs-AfricanAmerican |
9.998600E-01 |
| Caucasian-vs-Asian |
6.841400E-01 |
| AfricanAmerican-vs-Asian |
7.835200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.239900E-03 |
| Normal-vs-Female |
1.49599999055283E-09 |
| Male-vs-Female |
1.973730E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.69540001429647E-09 |
| Normal-vs-Age(41-60Yrs) |
1.95160000004968E-06 |
| Normal-vs-Age(61-80Yrs) |
2.188400E-02 |
| Normal-vs-Age(81-100Yrs) |
7.136000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.255500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.701500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.155000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.328810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.571000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.169400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.284000E-02 |
| Classical-VS-Follicular |
8.64770033359719E-10 |
| Classical-VS-Other |
2.115400E-01 |
| Classical-VS-Normal |
3.70109498604165E-11 |
| Tall-VS-Follicular |
3.86840000032862E-07 |
| Tall-VS-Other |
7.491600E-02 |
| Tall-VS-Normal |
2.70999999996135E-06 |
| Follicular-VS-Other |
4.445200E-01 |
| Follicular-VS-Normal |
8.872200E-01 |
| Other-VS-Normal |
5.581600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.806800E-04 |
| Normal-vs-N1 |
3.162800E-03 |
| N0-vs-N1 |
2.842800E-01 |
|
|
